Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dhiren Patel

Vascular Surgery Springfield, IL Medical Doctor

NPI 1619261062 CMS profile 4225460

800 N 1St St, Springfield, IL 62702

Open in the dashboard

General payments

$120,999

153 records reported · program years 2019–2025

Research payments

$1,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dhiren Patel of Springfield, IL is reported in the CMS Open Payments database as having received $120,999 across 153 general payments and $1,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $36,755 36
2025 Research $1,000 1
2024 General $42,259 45
2023 General $34,542 43
2022 General $6,635 20
2021 General $178 3
2020 General $13 1
2019 General $617 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dhiren Patel
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Dhiren Patel were reported at $36,755. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Dhiren Patel Vascular Surgery median Middle half National median
2019 $617 $796 $226–$2,363 $163
2020 $13 $348 $118–$1,110 $114
2021 $178 $471 $158–$1,421 $132
2022 $6,635 $725 $222–$2,183 $149
2023 $34,542 $836 $257–$2,440 $160
2024 $42,259 $909 $252–$2,619 $164
2025 $36,755 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Kerecis Limited $91,325 53 payments
  2. Inari Medical, Inc. $18,372 20 payments
  3. W. L. Gore & Associates, Inc. $2,845 17 payments
  4. Boston Scientific Corporation $2,429 8 payments
  5. Penumbra, Inc. $2,212 9 payments
  6. Abbott Laboratories $2,041 19 payments
  7. Silk Road Medical, Inc. $628 6 payments
  8. ETS Wound Care LLC $281 2 payments
  9. Royal Biologics $227 1 payment
  10. Integra LifeSciences Corporation $168 1 payment
  11. Other $472 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $58,950 8 payments
  2. Travel and Lodging $27,077 63 payments
  3. Consulting Fee $12,700 4 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,446 5 payments
  5. Food and Beverage $6,826 69 payments
  6. Education $5,000 4 payments
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose $57,093 30 payments
  2. Kerecis Omega3 Marigen Wound Care $35,272 23 payments
  3. Kerecis SurgiClose Wound Care $34,136 22 payments
  4. Kerecis GraftGuide $34,136 22 payments
  5. Kerecis SurgiClose Wound Care $34,136 22 payments
  6. Kerecis SurgiClose Wound Care $34,136 22 payments
  7. Kerecis SurgiClose Wound Care $34,136 22 payments
  8. Kerecis Omega3 Marigen Wound Care $29,780 19 payments
  9. Kerecis Omega3 Marigen Wound Care $29,780 19 payments
  10. Kerecis Omega3 Marigen Wound Care $29,780 19 payments
  11. Other $154,490 184 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Kerecis Limited $1,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

355

Median for Vascular Surgery: 122

Drug cost

$63,112

Median for Vascular Surgery: $14,135

Branded share of claims

53.8%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 77 $54,255
Xarelto Rivaroxaban Brand 11 $6,126
Clopidogrel Clopidogrel Bisulfate Brand 103 $1,107
Cilostazol Generic 42 $917
Doxycycline Monohydrate Generic 15 $240
Doxycycline Hyclate Generic 17 $181
Atorvastatin Calcium Generic 27 $115
Tramadol Hcl Generic 46 $99
Levofloxacin Generic 17 $72

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 137 billing codes

Paid by Medicare

$143,409

Medicare's payments for the services billed

Medicare patients

513

Average age 74

Services billed

1,387

240 women, 273 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 59%
Arthritis 51%
Diabetes 45%
Chronic kidney disease 41%
Heart failure 37%
COPD 34%
Atrial fibrillation 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record